PRA Health Sciences and Deep Lens Announce Strategic Relationship to Accelerate Patient Recruitment for Precision Cancer Trials

RALEIGH, N.C. and COLUMBUS, Ohio, Sept. 18 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ: PRAH) and Deep Lens, Inc., announced today a new strategic relationship to accelerate patient access and recruitment for oncology clinical trials. The relationship brings together best-in-class technologies that improve the identification, screening, and matching of cancer patients to precision-based clinical [...]